Eric D. Shaff
Director · Seres Therapeutics, Inc.
IndividualSelling only23 10b5-1 trades
- 2024
- Aug 18, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Eric D. Shaff files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Matthew R. Henn - $23K in MCRB purchases and sales in the last 12 months
- Teresa L. Young - $19K in MCRB purchases and sales in the last 12 months
- Thomas Desrosier - $3K in MCRB purchases and sales in the last 12 months
- Kelly Brady - $735 in MCRB purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Eric D. Shaff?
Eric D. Shaff is a corporate insider, tracked as Director of Seres Therapeutics, Inc. (MCRB). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Eric D. Shaff submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Eric D. Shaff been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($20K) across all tracked filings.
